Nonpartisan civic infrastructure
AllCiv·Legis1
·

S. 5502

BillFederalSenateIn Committee
A bill to ensure continued access to diabetes technology upon Medicare enrollment, and for other purposes.
About This Bill
Committee
Latest Action · December 12, 2024
Read twice and referred to the Committee on Finance.
Congress
118th (2023–2025)
Introduced
December 12, 2024
Cosponsors (1)
0D 1R
View PDF ↗

Summary

Highlight any text to annotate
The DIABETES Act addresses Medicare coverage gaps for people with diabetes by ensuring continued access to diabetes technology when seniors enroll in Medicare and expanding education services. The legislation requires the Secretary of Health and Human Services to establish a certification process allowing providers to document that new Medicare beneficiaries are already using covered diabetes devices like insulin pumps and continuous glucose monitors, ensuring they can keep using these technologies without interruption during their first year of enrollment. The bill also expands access to diabetes self-management training by removing limits on the quantity and duration of educational services deemed medically necessary, and requires Medicare to create new billing codes for insulin pump training and education services by January 1, 2026. Additionally, the Secretary must issue a proposed national coverage determination for insulin infusion pumps within 180 days of the law's enactment, and a Government Accountability Office report must assess barriers to diabetes technology access across all federal health programs by one year after enactment. Most provisions take effect on January 1, 2026, affecting the estimated 26 percent of Medicare beneficiaries who have diabetes.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.